Skip to main content

GALDY · Galderma Group AG · Webcasts, Transcripts & Audio

Track GALDY — free
$46.57 -0.84 (-1.77%) At close · Nov 6 Play latest call Q3 2026 earnings call transcript
Market Cap
$55.28B
Shares
1.17B
Volume · Nov 6 127.35K Avg daily vol (3M) 207.59K

Galderma Group AG Webcasts

Earnings calls, investor updates, investor days and conferences for Galderma Group AG (GALDY), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY27 · Q2
2027-07-22
Galderma Group AG (GALDY) Q2 2027 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-Q
Annual General Meeting
Investor event
2027-04-21
Galderma Group AG (GALDY) April 21, 2027 Annual General Meeting
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q4
2027-02-25
Galderma Group AG (GALDY) Q4 2026 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-K
Conference
Investor event
2026-12-09
Galderma Group AG (GALDY) December 9, 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Annual General Meeting
Investor event
2026-12-03
Galderma Group AG (GALDY) December 3, 2026 Annual General Meeting
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-12-03
Galderma Group AG (GALDY) December 3, 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-11-18
Galderma Group AG (GALDY) November 18, 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-11-18
Galderma Group AG (GALDY) November 18, 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q3
2026-10-22
Galderma Group AG (GALDY) Q3 2026 Earnings Call Transcript
Confident tone Profitability and margin guidance Injectable aesthetics expansion Dermatological skin care
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-07-23
Galderma Group AG (GALDY) Q2 2026 Earnings Call Transcript
Confident tone Neuromodulators and Dysport Guidance and margin Relabotulinum toxin A FDA complete response letter
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-04-23
Galderma Group AG (GALDY) Q1 2026 Earnings Call Transcript
Confident tone Dermatological skincare brands (Cetaphil, ELASTIN) Strong Q1 sales growth and broad outperformance U.S. tariffs and trade exposure
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-05
Galderma Group AG (GALDY) Q4 2025 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–12 of 12 webcasts
Key facts CIK 2021390 CUSIP 36321W105 13F (30d) 5 filings 5 filers Visit website Investor relations